Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,756 | 1,151 | 98.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $288.90 | 13 | 1.4% |
| Education | $130.53 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,940 | 125 | $0 (2024) |
| Biogen, Inc. | $1,706 | 106 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,112 | 48 | $0 (2024) |
| SK Life Science, Inc. | $969.49 | 73 | $0 (2024) |
| UCB, Inc. | $948.80 | 44 | $0 (2024) |
| GENZYME CORPORATION | $942.89 | 48 | $0 (2022) |
| ABBVIE INC. | $752.76 | 47 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $732.08 | 36 | $0 (2024) |
| Grifols USA, LLC | $660.17 | 30 | $0 (2024) |
| EMD Serono, Inc. | $621.41 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,087 | 88 | Abbott Laboratories ($280.27) |
| 2023 | $1,984 | 106 | Alexion Pharmaceuticals, Inc. ($300.77) |
| 2022 | $2,450 | 148 | Biogen, Inc. ($381.43) |
| 2021 | $2,868 | 175 | Biogen, Inc. ($568.87) |
| 2020 | $2,116 | 114 | GENZYME CORPORATION ($240.29) |
| 2019 | $3,398 | 185 | Teva Pharmaceuticals USA, Inc. ($388.36) |
| 2018 | $3,019 | 178 | Grifols USA, LLC ($286.93) |
| 2017 | $3,253 | 175 | Kedrion Biopharma Inc. ($366.08) |
All Payment Transactions
1,169 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Neurology | ||||||
| 12/11/2024 | SpringWorks Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.86 | General |
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Neuromodulation | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Rare Disease | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Rare Disease | ||||||
| 11/15/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $1.38 | General |
| 11/14/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $27.27 | General |
| 11/06/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: Neuromodulation | ||||||
| 11/06/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Neuromodulation | ||||||
| 11/05/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Neuroscience | ||||||
| 11/02/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Neuropsychiatry | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Rare Disease | ||||||
| 10/09/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Neurology | ||||||
| 10/09/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $10.43 | General |
| Category: Neurology | ||||||
| 10/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,101 | 3,083 | $312,988 | $119,451 |
| 2022 | 12 | 1,017 | 2,481 | $258,038 | $98,757 |
| 2021 | 11 | 948 | 2,490 | $240,868 | $93,069 |
| 2020 | 12 | 871 | 2,493 | $229,157 | $96,098 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2023 | 220 | 2,022 | $129,982 | $52,724 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 109 | $27,918 | $9,522 | 34.1% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2023 | 85 | 87 | $20,436 | $8,256 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 134 | $24,422 | $7,554 | 30.9% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2023 | 195 | 200 | $18,046 | $7,275 | 40.3% |
| 95861 | Needle measurement of electrical activity in arm or leg muscles, 2 extremities | Facility | 2023 | 71 | 74 | $11,860 | $4,786 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $11,762 | $4,237 | 36.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $10,166 | $4,098 | 40.3% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 86 | 87 | $9,744 | $3,996 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 28 | $10,084 | $3,855 | 38.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 30 | 49 | $9,492 | $3,714 | 39.1% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 20 | 22 | $7,680 | $2,909 | 37.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,068 | $1,479 | 36.4% |
| 95870 | Needle measurement of electrical activity in arm, leg, trunk or head muscles, limited study | Facility | 2023 | 64 | 81 | $3,094 | $1,265 | 40.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 12 | 20 | $4,200 | $1,053 | 25.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 11 | 49 | $5,390 | $824.69 | 15.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 18 | 18 | $1,620 | $663.30 | 40.9% |
| 95955 | Measurement of brain wave activity (eeg) outside the brain during surgery | Facility | 2023 | 15 | 15 | $1,560 | $641.68 | 41.1% |
| 95868 | Needle measurement of electrical activity in muscles on both sides of body | Facility | 2023 | 12 | 12 | $1,464 | $598.71 | 40.9% |
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | Facility | 2022 | 219 | 1,589 | $106,030 | $42,381 | 40.0% |
| 95861 | Needle measurement of electrical activity in arm or leg muscles, 2 extremities | Facility | 2022 | 188 | 192 | $31,828 | $12,936 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 143 | $25,640 | $8,990 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 98 | $24,580 | $8,324 | 33.9% |
| 95939 | Placement of skin electrodes and measurement of central motor stimulation in arms and legs | Facility | 2022 | 76 | 78 | $18,924 | $7,560 | 40.0% |
| 95938 | Placement of skin electrodes and measurement of stimulated sites on arms and legs | Facility | 2022 | 171 | 174 | $18,286 | $6,453 | 35.3% |
About Dr. Danny Chachere, M.D
Dr. Danny Chachere, M.D is a Neurology healthcare provider based in Bellaire, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2011. The National Provider Identifier (NPI) number assigned to this provider is 1982994448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danny Chachere, M.D has received a total of $21,175 in payments from pharmaceutical and medical device companies, with $2,087 received in 2024. These payments were reported across 1,169 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($20,756).
As a Medicare-enrolled provider, Chachere has provided services to 3,937 Medicare beneficiaries, totaling 10,547 services with total Medicare billing of $407,376. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology, Neurology
- Location Bellaire, TX
- Active Since 04/18/2011
- Last Updated 05/05/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1982994448
Products in Payments
- AUBAGIO (Drug) $690.75
- Gamunex-C (Biological) $660.17
- APTIOM (Drug) $571.07
- TYSABRI (Biological) $564.04
- NUPLAZID (Drug) $562.41
- Hizentra (Biological) $540.50
- INGREZZA (Drug) $528.97
- AUSTEDO (Drug) $518.73
- AJOVY (Drug) $515.18
- EMGALITY (Drug) $513.78
- SOLIRIS (Drug) $504.35
- UBRELVY (Drug) $497.44
- AJOVY (Biological) $495.66
- NURTEC ODT (Drug) $492.57
- INFINITY (Device) $467.97
- NUEDEXTA (Drug) $435.55
- TROKENDI XR (Drug) $430.13
- Vimpat (Drug) $414.98
- VUMERITY (Drug) $390.85
- MIGRANAL (Drug) $385.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bellaire
Dr. Brian Loftus, M.d, M.D
Neurology — Payments: $254,736
Dr. Stacy Smith, M.d, M.D
Neurology — Payments: $206,117
Dr. Mary Vanderlick, Md, MD
Neurology — Payments: $43,533
Dr. William Irr, Md, MD
Neurology — Payments: $35,337
Dr. Sonia Krish, M.d, M.D
Neurology — Payments: $185.27
Maureen Handoko-Yang, Md, Phd, MD, PHD
Neurology — Payments: $93.41